Debasis Das MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Join to View Full Profile
10100 Kanis RdLittle Rock, AR 72205
Phone+1 501-255-6000
Fax+1 501-255-6400
Dr. Das is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified interventional cardiologist, performing coronary and peripheral arterial interventions, PFO and ASD closures.
Also practice general and nuclear cardiology.
Education & Training
University of Louisville School of MedicineFellowship, Interventional Cardiology, 2000 - 2001
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Cardiovascular Disease, 1997 - 2000
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1993 - 1995
Medical College and Hospital KolkataClass of 1985
Certifications & Licensure
AR State Medical License 2001 - 2026
KY State Medical License 2000 - 2002
OH State Medical License 1995 - 2001
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsAre small-sized mechanical valves adequate for patients with small aortic roots?Pratik Pandey, Apu Saha, Neeraj Kumar Jha, Yashaskar Manjunatha Rao, Debasis Das
Asian Cardiovascular & Thoracic Annals. 2022-11-01 - 1 citationsOn-pump beating heart versus off-pump myocardial revascularization—a propensity-matched comparisonYashaskar Manjunatha Rao, Shreyas Potdar, Debasis Das, Atanu Saha, Lalit Kapoor
Indian Journal of Thoracic and Cardiovascular Surgery. 2021-10-06 - 11 citationsIn vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models.Debasis Das, Lingzhi Xie, Jingbing Wang, Jingli Shi, Jian Hong
Bioorganic Chemistry. 2020-03-24
Press Mentions
A Conserved Two-Component System Senses Intracellular Iron Levels and Regulates Redox Balance in Mycobacterium SppSeptember 24th, 2024- After Transplant, 13-Year-Old Becomes Youngest Heart Recipient in East IndiaMarch 3rd, 2021
- Kolkata: After Transplant, 13-Year-Old Becomes Youngest Heart Recipient in East IndiaMarch 3rd, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
